Type in product code or name:
Code | Name | Applications | Availability | Size | Tested species | Price | Grade | |
---|---|---|---|---|---|---|---|---|
EB08353 | Goat Anti-Frizzled 2 Antibody | Pep-ELISA, WB, IF, IHC | 100µg specific antibody in 200µl | Human | $450.00 | |||
Ordering Information forOrder direct from Everest
$73.00: Overnight shipping to United States of America
Sent via overnight courier arrives approximately next day to mainland USA. Please note that your order will be shipped by our parent company Vector Laboratories. Order offline99% of products are held in stock for immediate shipment, see individual product pages for availability. Please order through the US Dollar shopping cart (links on each product page) or we accept orders by email ([email protected]) Please include the following information with your order:
In stock orders received by 11 am PST on Monday through Friday are shipped the same day. Orders are shipped by our parent company Vector Laboratories, 6737 Mowry Avenue, Newark CA 94560, USA. |
Peptide with sequence RYATLEHPFHCPR, from the internal region of the protein sequence according to NP_001457.1.
Please note the peptide is available for sale.
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20°C. Minimize freezing and thawing.
Immunofluorescence: Strong expression of the protein seen in the nuclei and cytoplasm of U2OS cells. Recommended concentration: 10µg/ml.
This antibody has been successfully used in IHC:
Alexandra Maráczi, Béla Kajtár, Ádám Nagy, Eszter Györke, Petra Görög, Józsefné Kurucz, Bernadette Kálmán, Ferenc Garzuly
Case report: molecular analysis of congenital glioblastoma in a newborn
Magy Onkol. 2022 Jun 20;66(2):162-167.
PMID: 35724395
This antibody has been successfully used in IHC on Human:
Hirano H, Yonezawa H, Yunoue S, Habu M, Uchida H, Yoshioka T, Kishida S, Kishida M, Oyoshi T, Fujio S, Sugata S, Yamahata H, Hanaya R, Arita K.
Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostaining.
Brain Tumor Pathol. 2014 Apr;31(2):85-93.
PMID: 23748645